The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 8,401–8,500 of 31,469
Huhtaniemi, I. T., Pye, S. R., Holliday, K. L., Thomson, W., O’Neill, T. W., Platt, H., Payne, D., John, S., Jiang, M., Bártfai, G., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2071 · Cited by 43
Association of urine acidification with visceral obesity and the metabolic syndrome
Otsuki, M., Kitamura, T., Goya, K., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-319 · Cited by 43
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., Takayama, S., Abe, M., Katoh, T., & Ohtsuka, N. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-87 · Cited by 43
Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study.
Lorenzo, C., Hazuda, H., & Haffner, S. (2012) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2011-2272 · Cited by 44
Comparative Evaluation of Simple Indices of Graft Function After Islet Transplantation
Caumo, A., Maffi, P., Nano, R., Luzi, L., Hilbrands, R., Gillard, P., Jacobs‐Tulleneers‐Thevissen, D., Secchi, A., Keymeulen, B., PIPELEERS, D. G., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31822ca79b · Cited by 43
Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line
Shimizu, A., Takamura, T., Matsuzawa, N., Nakamura, S., Nabemoto, S., Takeshita, Y., Misu, H., Kurita, S., Sakurai, M., Yokoyama, M., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.013 · Cited by 43
Mannino, G. C., Greco, A., Lorenzo, C. D., Andreozzi, F., Marini, M. A., Perticone, F., & Sesti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085483 · Cited by 43
Higher Metabolic Syndrome in Obese Asthmatic Compared to Obese Nonasthmatic Adolescent Males
Del-Rio-Navarro, B. E., Castro-Rodríguez, J. A., Garibay-Nieto, N., Berber, A. C., Toussaint, G., Sienra-Monge, J. J. L., & Romieu, I. (2010) · Journal of Asthma · doi:10.3109/02770901003702808 · Cited by 42
Therapeutic Fasting in Patients with Metabolic Syndrome and Impaired Insulin Resistance
Stange, R., Pflugbeil, C., Michalsen, A., & Uehleke, B. (2013) · Complementary Medicine Research · doi:10.1159/000357875 · Cited by 43
Circulating chemerin decreases in response to a combined strength and endurance training
Stefanov, T., Blüher, M., Vekova, A., Bonova, I., Tzvetkov, S., Kurktschiev, D. P., & Temelkova-Kurktschiev, T. S. (2013) · Endocrine · doi:10.1007/s12020-013-0003-2 · Cited by 43
Wu, L. H., Huang, C., Adhikarakunnathu, S., Mateo, L. R. S., Duffy, K. E., Rafferty, P., Bugelski, P. J., Raymond, H. A., Deutsch, H., Picha, K. M., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.04.015 · Cited by 44
Park, M. ‐., Kim, N., Lee, J., & Park, H. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.081000 · Cited by 45
Ito, H., Ohshima, A., Tsuzuki, M., Ohto, N., Yanagawa, M., Maruyama, T., Kaji, Y., Kanaya, S., & Nishioka, K. (2001) · Japanese Heart Journal · doi:10.1536/jhj.42.459 · Cited by 43
Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose
Voldner, N., Qvigstad, E., Frøslie, K. F., Godang, K., Henriksen, T., & Bollerslev, J. (2009) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903121472 · Cited by 43
George, J. A., Venter, F., van Deventer, H. E., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0308 · Cited by 43
Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause
Soriguer, F., Morcillo, S., Hernando, V., Valdés, S., de Adana, M. S. R., Olveira, G., García‐Fuentes, E., González, I., Tapia, M. J., Esteva, I., et al. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31819d4113 · Cited by 43
Mujumdar, P. P., Duerksen-Hughes, P. J., Firek, A. F., & Hessinger, D. A. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.554995 · Cited by 45
Metabolic normality in overweight and obese subjects. Which parameters? Which risks?
the RISC Investigators, Pataky, Z., Makoundou, V., Nilsson, P., Gabriel, R., Lalic, K. S., Muscelli, E., Casolaro, A., Golay, A., & Bobbioni-Harsch, E. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.264 · Cited by 43
Grarup, N., Albrechtsen, A., Ek, J., Borch‐Johnsen, K., Jørgensen, T., Schmitz, O., Hansen, T. F., & Pedersen, O. B. (2007) · Diabetologia · doi:10.1007/s00125-007-0668-2 · Cited by 43
Zhang, J., NIAURA, R. S., Dyer, J. R., Shen, B., Todaro, J. F., McCaffery, J. M., Spiro, A., & Ward, K. D. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000228343.89466.11 · Cited by 44
Lawlor, D. A., Sattar, N. A., Sayers, A. E., & Tobias, J. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2721 · Cited by 43
de Melo, A. S., Vieira, C. S., Romano, L. G. M., Ferriani, R. A., & Navarro, P. A. (2011) · Reproductive Sciences · doi:10.1177/1933719111414205 · Cited by 43
The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial
Buse, J. B., Wolffenbuttel, B. H. R., Herman, W. H., Hippler, S. E., Martin, S., Jiang, H. H., Shenouda, S. K., & Fahrbach, J. L. (2011) · Diabetes Care · doi:10.2337/dc10-1701 · Cited by 45
Montomoli, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i3.348 · Cited by 43
Jin, H.-M., & Pan, Y. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm049 · Cited by 43
McAllan, L., Keane, D., Schellekens, H., Roche, H. M., Korpela, R., Cryan, J. F., & Nilaweera, K. N. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513001396 · Cited by 43
Kelly, A. S., Dengel, D. R., Hodges, J., et al. (2014) · Clinical Obesity · doi:10.1111/cob.12044 · Cited by 43
Gökçe, S., Atbinici, Z., Aycan, Z., et al. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0447-9 · Cited by 43
Total plasma homocysteine correlates in women with gestational diabetes
Idzior−Waluś, B., Cyganek, K., Sztefko, K., Seghieri, G., Breschi, M. C., Waluś‐Miarka, M., Kawalec, E., Seretny, M., & Sieradzki, J. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0571-1 · Cited by 44
Hattori, T., Murase, T., Takatsu, M., Nagasawa, K., Matsuura, N., Watanabe, S., Murohara, T., & Nagata, K. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001312 · Cited by 44
Sidhwani, S., Scoccia, B., Sunghay, S., Stephens, C. N., Mazzone, T., & Sam, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04015.x · Cited by 43
Kawamura, R., Doi, Y., Osawa, H., Ninomiya, T., Hata, J., Yonemoto, K., Tanizaki, Y., Iida, M., Makino, H., & Kiyohara, Y. (2010) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfq155 · Cited by 45
Visceral fat and coronary artery calcification in patients with chronic kidney disease
Cordeiro, A. C., Qureshi, A. R., Lindholm, B., Amparo, F. C., Tito-Paladino-Filho, A., Perini, M., Lourenco, F. S., Pinto, I. M. F., Amodeo, C., & Carrero, J. J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft250 · Cited by 43
Oranta, O., Pahkala, K., Ruottinen, S., Niinikoski, H., Lagström, H., Viikari, J. S. A., Jula, A., Loo, B.-M., Simell, O., Rönnemaa, T., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0361 · Cited by 44
Bari, M. F., Weickert, M. O., Sivakumar, K., James, S. G., Snead, D. R. J., Tan, B. K., Randeva, H. S., Bastie, C. C., & Vatish, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101327 · Cited by 43
Silva, L. D. S. E. (2014) · Journal of Clinical Medicine Research · doi:10.14740/jocmr1580w · Cited by 43
Khatibi, A., Agardh, C. –., Shakir, Y. A., Nerbrand, C., Nyberg, P., Lidfeldt, J., & Samsioe, G. (2007) · Climacteric · doi:10.1080/13697130701377265 · Cited by 43
Circulating micrornas associated with glycemic impairment and progression in Asian Indians
Flowers, E., Gadgil, M. D., Aouizerat, B. E., & Kanaya, A. M. (2015) · Biomarker Research · doi:10.1186/s40364-015-0047-y · Cited by 43
Imai, K., Takai, K., Nishigaki, Y., Shimizu, S., Naiki, T., Hayashi, H., Uematsu, T., Sugihara, J., Tomita, E., Shimizu, M., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00616.x · Cited by 43
Oh, S., Tanaka, K., Tsujimoto, T., So, R., Shida, T., & Shoda, J. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0143 · Cited by 43
Impact of obesity and insulin-resistance on cirrhosis and portal hypertension
Berzigotti, A., & Abraldeṣ, J. G. (2013) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2013.03.005 · Cited by 43
Morcillo, S., Martín‐Núñez, G. M., Rojo‐Martínez, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021198 · Cited by 43
Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults
Zhang, T., Zhang, H., Li, S., Li, Y., Liu, Y., Fernandez, C., Harville, E. W., Bazzano, L., He, J., & Chen, W. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06509 · Cited by 43
Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy
Erlandson, K. M., Jiang, Y., Debanne, S. M., & McComsey, G. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ554 · Cited by 43
Adam, S. H., Giribabu, N., Pasupuleti, V. R., Sayem, A. S. M., Arya, A., Panichayupakaranant, P., Korla, P. K., & Salleh, N. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.028 · Cited by 43
Marouga, A., Dalamaga, Μ., Kastania, A., et al. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1118536 · Cited by 43
Ayuob, N. N., & Elbeshbeishy, R. A. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149191 · Cited by 46
Zeng, T., Zhou, J., He, L., Zheng, J., Chen, L., Wu, C., & Xia, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149677 · Cited by 44
Dynamics of circulating microparticles in obesity after weight loss
Campello, E., Zabeo, E., Radu, C. M., Spiezia, L., D, M. F. M., Prevedello, L., Gavasso, S., Bulato, C., Vettor, R., & Simioni, P. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1397-7 · Cited by 43
Shawky, N. M., Pichavaram, P., Shehatou, G. S. G., Suddek, G. M., Gameil, N. M., Jun, J. Y., & Segar, L. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.009 · Cited by 43
Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome
Abalı, R., Yüksel, İ. T., Yüksel, M. A., Bulut, B., İmamoğlu, M., Emirdar, V., Ünal, F., Güzel, S., & Celik, C. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2016.1174200 · Cited by 43
An, J. H., Kim, D., Lee, T., Kim, K. J., Kim, S. H., Kim, N. H., Kim, H. Y., Choi, D. S., & Kim, S. G. (2016) · Phytotherapy Research · doi:10.1002/ptr.5664 · Cited by 43
Lipovec, N. Č., Schols, A. M. W. J., van den Borst, B., Beijers, R. J. H. C. G., Kosten, T., Omersa, D., & Lainščak, M. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.05.002 · Cited by 46
Ahern, T., Święcicka, A., Eendebak, R. J. A. H., Carter, E. L., Finn, J. D., Pye, S. R., O’Neill, T. W., Antonio, L., Keevil, B. G., Bártfai, G., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13152 · Cited by 43
Berryman, C. E., Agarwal, S., Lieberman, H. R., Fulgoni, V. L. I., & Pasiakos, S. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.133819 · Cited by 44
Metabolic syndrome: prevalence and risk factors in Korean gout patients
Jung, J. H., Song, G. G., Ji, J. D., et al. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.062 · Cited by 43
Wu, X., Wang, J., Shi, Y., Chen, S., Yan, Q., Jiang, Z., & Jing, H. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.11.012 · Cited by 44
Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria
Moretti, F., Pellegrini, N., Salvatici, E., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.11.002 · Cited by 43
Matsuzaki, T., Munkhzaya, M., Iwasa, T., Tungalagsuvd, A., Yano, K., Mayila, Y., Yanagihara, R., Tokui, T., Kato, T., Kuwahara, A., et al. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0501 · Cited by 45
Valsamakis, G., Papatheodorou, D. C., Chalarakis, N., Vrachnis, N., Sidiropoulou, E. J., Manolikaki, M., Mantzou, A., Margeli, A., Papassotiriou, I., Chrousos, G. P., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.06.008 · Cited by 44
Souto, K. P., Meinhardt, N. G., Ramos, M. J., Kulczynski, J. M. U., Stein, A. T., & Damin, D. C. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.09.527 · Cited by 44
Cho, D. K., Choi, D. H., & Cho, J. Y. (2017) · Physical Activity and Nutrition · doi:10.20463/jenb.2017.0013 · Cited by 43
DiNicolantonio, J. J., Bhutani, J., O’Keefe, J. H., & Crofts, C. A. P. (2017) · Open Heart · doi:10.1136/openhrt-2017-000656 · Cited by 46
Breastfeeding and Maternal Hypertension
Park, S., & Choi, N. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx219 · Cited by 43
Gong, P., Shi, B., Wang, J., Cao, P., Diao, Z., Wang, Y., Hu, Y., & Li, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428301 · Cited by 43
Veeramani, C., Alsaif, M. A., & Al‐Numair, K. S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.04.009 · Cited by 43
Abdominal obesity and insulin resistance after an episode of acute pancreatitis
Singh, R. G., Pendharkar, S. A., Cervantes, A., Cho, J., Miranda-Soberanis, V., & Petrov, M. S. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.04.023 · Cited by 43
Barazzoni, R., Cappellari, G. G., Semolic, A., Ius, M., Zanetti, M., Gabrielli, A., Vinci, P., Guarnieri, G., & Simon, G. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.014 · Cited by 46
Ebrahimi-Mameghani, M., Jafarabadi, M. A., & Rezazadeh, K. (2018) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2018.05.006 · Cited by 43
Johnson, L. C., Martens, C. R., Santos‐Parker, J. R., Bassett, C. J., Strahler, T. R., Cruickshank-Quinn, C. I., Reisdorph, N. A., McQueen, M. B., & Seals, D. R. (2018) · Clinical Science · doi:10.1042/cs20180409 · Cited by 45
Thiesse, L., Rudzik, F., Spiegel, K., Leproult, R., Pieren, R., Wunderli, J. M., Foraster, M., Héritier, H., Eze, I. C., Meyer, M., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.05.036 · Cited by 43
Esfandiari, A., Gargari, B. P., Noshad, H., Sarbakhsh, P., Mobasseri, M., Barzegari, M., & Arzhang, P. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.09.013 · Cited by 44
Dhayat, N. A., Marti, N., Kollmann, Z., Troendle, A., Bally, L., Escher, G., Groessl, M., Ackermann, D., Ponte, B., Pruijm, M. T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203903 · Cited by 46
Association between C-Reactive Protein and Metabolic Syndrome in Korean Adults
Song, Y., Yang, S. K., Kim, J., & Lee, D. (2018) · Korean Journal of Family Medicine · doi:10.4082/kjfm.17.0075 · Cited by 43
Zhu, Y., Hedderson, M. M., Quesenberry, C. P., Feng, J., & Ferrara, A. M. (2018) · Obesity · doi:10.1002/oby.22339 · Cited by 47
González‐Cantero, Á., Gonzalez-Calvin, J. L., Sánchez‐Moya, A. I., Pérez‐Hortet, C., Arias‐Santiago, S., Schöendorff‐Ortega, C., & Gonzalez-Calvin, J. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211808 · Cited by 43
Koloverou, E., Panagiotakos, D. B., Kyrou, I., Stefanadis, C., Chrysohoou, C. A., Georgousopoulou, E. N., Skoumas, I., Tousoulis, D. M., Pitsavos, C. E., & the ATTICA Study group (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3161 · Cited by 43
Bermúdez‐Millán, A., Wagner, J. A., Feinn, R., Segura‐Pérez, S., Damio, G., Chhabra, J., & Pérez‐Escamilla, R. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz021 · Cited by 44
Owei, I., UMEKWE, N. A., Stentz, F. B., Wan, J. Y., & Dagogo-Jack, S. E. (2019) · Metabolism · doi:10.1016/j.metabol.2019.06.011 · Cited by 43
Mutavdžin, S., Gopčević, K., Stankovic, S. D., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1342549 · Cited by 43
The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women
Fu, C., Ali, H., Rachakonda, V. P., Oczypok, E. A., DeLany, J. P., & Kershaw, E. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224942 · Cited by 43
Min, T., Prior, S. L., Dunseath, G. J., Churm, R., Barry, J. D., & Stephens, J. W. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04377-3 · Cited by 46
Al‐Sofiani, M. E., Langan, S. J., Kanaya, A. M., Kandula, N. R., Needham, B. L., Kim, C., Vaidya, D. M., Golden, S. H., Gudzune, K. A., & Lee, C. J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108052 · Cited by 45
Chen, G., Chai, J. C., Yu, B., Michelotti, G. A., Grove, M. L., Fretts, A. M., Daviglus, M. L., Garcia‐Bedoya, O., Thyagarajan, B., Schneiderman, N., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa114 · Cited by 46
Shetty, S. S., Kumari, S., & Shetty, P. K. (2020) · Nutrition · doi:10.1016/j.nut.2020.110968 · Cited by 43
Triglyceride‐Glucose Index (TyG) is associated with erectile dysfunction: A cross‐sectional study
Yılmaz, M., Karaaslan, M., Tonyalı, Ş., Celik, M., Toprak, T., & Odabaş, Ö. (2020) · Andrology · doi:10.1111/andr.12904 · Cited by 44
Toejing, P., Khat‐udomkiri, N., Intakhad, J., Sirilun, S., Chaiyasut, C., & Lailerd, N. (2020) · Nutrients · doi:10.3390/nu12103015 · Cited by 44
Toppala, S., Ekblad, L. L., Tuisku, J., Helin, S., Johansson, J. J., Laine, H. K., Löyttyniemi, E., Marjamäki, P., Blennow, K., Zetterberg, H., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011612 · Cited by 45
The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis—Dysregulation by the Liver
London, A., Lundsgaard, A., Kiens, B., & Bojsen-Møller, K. N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030390 · Cited by 46
Andersson-Hall, U. K., Joelsson, L., Svedin, P., Mallard, C. E., & Holmäng, A. B. (2021) · Clinical Endocrinology · doi:10.1111/cen.14433 · Cited by 42
Association of Serum Levels of Zinc, Copper, and Iron with Risk of Metabolic Syndrome
Lu, C., Lee, Y.-C., Kuo, C.-S., Chiang, C., Chang, H., & Huang, K. (2021) · Nutrients · doi:10.3390/nu13020548 · Cited by 44
Insulin resistance accounts for metabolic syndrome‐related alterations in brain structure
Lu, R., Aziz, N. A., Diers, K., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25377 · Cited by 43
Lischka, J., Schanzer, A., Baumgartner-Kaut, M., de Gier, C., Greber‐Platzer, S., & Zeyda, M. (2022) · Nutrients · doi:10.3390/nu14020286 · Cited by 44
Mohamed, D. I., El-Waseef, D. A. E.-D. A., Nabih, E. S., El-Kharashi, O. A., El-Kareem, H. F. A., Nahas, H. H. A., Abdel‐Wahab, B. A., Helmy, Y. A., Alshawwa, S. Z., & Saied, E. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030529 · Cited by 45
Shaaban, H. H., AlZaim, I., El‐Mallah, A., Aly, R. G. M., EL‐Yazbi, A. F., & Wahid, A. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120956 · Cited by 42
Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study
Soriguer, F., Rubio‐Martín, E., Fernández, D., Valdés, S., García‐Escobar, E., Martín‐Núñez, G. M., Esteva, I., Almaraz, M. C., & Rojo‐Martínez, G. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02559.x · Cited by 43
Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters.
Park, S. H., Jeon, W. K., Kim, S. H., et al. (2005) · PubMed · Cited by 43
The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease
Pürnak, T., Beyazıt, Y., Özaslan, E., Efe, C., & Hayretci, M. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0211-4 · Cited by 43
Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet‐fed mice
Duplain, H., Sartori, C. S., Dessen, P., et al. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.154302 · Cited by 43
Lewandowski, K. C., Cajdler-Łuba, A., Salata, I., Bieńkiewicz, M., & Lewiñski, A. (2011) · PubMed · Cited by 43
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
